Yanfeng Liu

Dr. Yanfeng Liu


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 August 2024 in International Journal of Surgery
Verified
Journal Article
Open access
QYQiong Yang
Qiong Yang
JSJingxian Sun
Jingxian Sun
Zhao YangZhao Yang
Zhao Yang
SRSanjay Rastogi
Sanjay Rastogi
YLYanfeng Liu
Yanfeng Liu
BZBinbin Zhao
Binbin Zhao
Background: Surgical site infection (SSI) is the prevailing complication that occurs after surgery and significantly escalates healthcare expenses. Published meta-analyses and international standards vary in their recommendations for the most effective preoperative skin antiseptic solution and concentration. Objective: The aim of this systematic review and meta-analysis is to assess the effectiveness of chlorhexidine-alcohol compared to aqueous/alcoholic iodine solutions in preventing postoperative surgical site infections. Methods: A systematic search was conducted using four electronic databases (PubMed, Embase, Scopus, and Cochrane Library) to select publications published in peer-reviewed journals. The risk ratio (RR) was calculated, along with their 95% confidence intervals. We assessed heterogeneity using Cochrane Q and I 2 statistics and the appropriate P value. The analysis used RevMan 5.4. Results: The current meta-analysis includes 14 randomized controlled trials (RCTs) comparing either 2–2.5% chlorhexidine-alcohol with aqueous/alcoholic iodine. It was demonstrated that the CAG-using group had an overall lower incidence of postoperative surgical site infections compared to the iodine-using group (RR=0.30, 95% CI=0.20–0.46, I 2=95%, P<0.00001). It exhibits comparable efficacy across various surgical procedures, as evidenced by its RR of 0.25 [95% CI 0.15–0.41], I 2=51%, and P<0.0001 for general surgery, RR=0.47 [95% CI 0.32–0.67], I 2=82%, P=0.0002 for cesarean section and RR of 0.47 [95% CI 0.34–0.65], I 2=76% and P<0.00001 for additional surgical procedures, including neurosurgery, orthopedic surgery, etc. Conclusion: This meta-analysis suggests using either 2.0–2.5% chlorhexidine in alcohol instead of aqueous, alcoholic iodine to prevent SSIs in adult patients undergoing surgery. Chlorhexidine in alcohol worked effectively for general surgery, cesarean sections, and other surgeries. Thus, preoperative skin cleansing with chlorhexidine-alcohol minimizes postoperative SSIs and bacterial colonization in diverse procedures.

14 November 2022 in Frontiers in Oncology
Verified
Journal Article
Open access
JWJianlei Wang
Jianlei Wang
JSJianping Song
Jianping Song
ZLZeyang Liu
Zeyang Liu
TZTingxiao Zhang
Tingxiao Zhang
YLYanfeng Liu
Yanfeng Liu
Objective: Colorectal cancer (CRC) is a common type of malignant tumor of the digestive tract. Tumor mutation burden (TMB) is a potential prognostic indicator of numerous malignant tumors. This study investigated the prognostic value of TMB in CRC.Methods: This study analyzed the clinical and somatic mutation data of patients with CRC from the Memorial Sloan Kettering Cancer Center (MSKCC) and The Cancer Genome Atlas (TCGA) cohorts. The genetic landscape was visualized using the maftools package in R software. Survival curves were constructed using the Kaplan–Meier method, and Cox regression analysis was performed to confirm that TMB is an independent prognostic indicator. A nomogram was developed to construct the prognostic model, which was evaluated using the C-index, calibration curve, and decision curve analysis.Results: In patients with CRC, APC mutations indicated longer overall survival (OS), whereas KRAS mutations indicated shorter OS. For all included patients, there was no significant difference in the OS between the TMB-high and TMB-low groups. For patients with KRAS mutations, the OS in the TMB-high group was longer than that in the TMB-low group. Cox regression analysis showed that TMB was an independent prognostic factor in CRC patients with KRAS mutations. This explains the good accuracy of the nomogram prognostic model using TMB and indicates its good prospect in clinical applications.Conclusions: A high TMB indicates better prognosis in CRC patients with KRAS mutations, thus confirming the value of TMB in clinical applications.

29 October 2021 in Cell Death Discovery
Verified
Journal Article
Open access
PDF file
JSJianping Song
Jianping Song
DCDonghai Cui
Donghai Cui
JWJing Wang
Jing Wang
JQJunchao Qin
Junchao Qin
SWShourong Wang
Shourong Wang
ZLZhaojian Liu
Zhaojian Liu
Cholangiocarcinomas (CCAs) are rare but aggressive tumors of the bile ducts. CCAs are often diagnosed at an advanced stage and respond poorly to current conventional radiotherapy and chemotherapy. High mobility group A1 (HMGA1) is an architectural transcription factor that is overexpressed in multiple malignant tumors. In this study, we showed that the expression of HMGA1 is frequently elevated in CCAs and that the high expression of this gene is associated with a poor prognosis. Functionally, HMGA1 promotes CCA cell proliferation/invasion and xenograft tumor growth. Furthermore, HMGA1 transcriptionally activates RAD51 by binding to its promoter through two HMGA1 response elements. Notably, overexpression of HMGA1 promotes radioresistance whereas its knockdown causes radiosensitivity of CCA cells to X-ray irradiation. Moreover, rescue experiments reveal that inhibition of RAD51 reverses the effect of HMGA1 on radioresistance and proliferation/invasion. These findings suggest that HMGA1 functions as a novel regulator of RAD51 and confers radioresistance in cholangiocarcinoma.

21 January 2022 in World Journal of Clinical Cases
Verified
Journal Article
Open access
JSJian-Ping Song
Jian-Ping Song
XLXue-Zhi Liu
Xue-Zhi Liu
QCQian Chen
Qian Chen
YLYanfeng Liu
Yanfeng Liu
Intrahepatic cholangiocarcinoma (ICC) is malignancies of the biliary duct system and constitutes approximately 10%-20% of all primary liver cancers. Tumor mutation burden (TMB) is a useful biomarker across many cancer types for the identification of patients who will benefit from immunotherapy. Despite the role of TMB in calculating the effectiveness and prognosis of immune checkpoint inhibitors has been confirmed in multiple human cancer types, the prognostic value of TMB in ICC patients is rare investigated. To investigate the prognostic value of TMB in patients with ICC. Data of 412 patients with ICC were included in the study. TMB was calculated as the total number of somatic non-silent protein-coding mutations divided by the coding region. The Kaplan-Meier method was used to analyze overall survival (OS), and relapse free survival (RFS). The cut-off value of TMB was determined by time-dependent receiver operating characteristic (ROC) curve. Cox regression was performed for multivariable analysis of OS. The nomogram and calibration curve were analyzed to construct and evaluate the prognostic model. In the analysis of the time-dependent ROC curve, we defined 3.1 mut/Mb as the cut-off value of TMB. The Kaplan-Meier plot revealed that patients with high TMB had poor OS (HR = 1.47, P = 0.002) and RFS (HR = 1.42, P = 0.035). Cox regression analysis also demonstrated that TMB was an independent risk predictor for ICC (HR = 1.43, P = 0.0240). Furthermore, independent prognostic factors of ICC included CA19-9 (HR = 1.78, P = 0.0005), chronic viral hepatitis (HR = 1.72, P = 0.0468), tumor resection (HR = 2.58, P < 0.0001) and disease progression (metastatic disease vs. solitary liver tumor; HR = 2.55, P = 0.0002). The nomogram and calibration curve also indicated the effectiveness of the constructed prognostic model. TMB was an independent prognostic biomarker in patients with ICC. Moreover, patients with ICC with high TMB had poor OS and RFS as compared to those with low TMB.

20 February 2023 in iLIVER
Verified
Journal Article
Open access
JSJianping Song
Jianping Song
JSJingxian Sun
Jingxian Sun
SJShuhong Jing
Shuhong Jing
TZTingxiao Zhang
Tingxiao Zhang
JWJianlei Wang
Jianlei Wang
YLYanfeng Liu
Yanfeng Liu
Secreted phosphoprotein 1 (SPP1) functions in several physiological processes. The role of SPP1 expression in the prognosis and tumor immunity of hepatocellular carcinoma (HCC) is unknown. The aim of this study was to investigate the expression pattern of SPP1 in HCC and its correlation with prognosis and tumor immunity. Clinical and gene expression data of The Cancer Genome Atlas-liver hepatocellular carcinoma (LIHC) cohort and 11 other HCC datasets were collected. The Kaplan–Meier method and Cox regression analysis were used to analyze the prognostic value of SPP1. The DESeq2 package in R was used to analyze SPP1-related genes. Gene Ontology analysis and gene set enrichment analysis were used to determine the biological function of SPP1 in HCC. The single sample Gene Set Enrichment Analysis (ssGSEA) method was used to analyze the immune infiltrates of HCC. Illumina human methylation 450 data and level 3 HTSeq-FPKM data from The Cancer Genome Atlas-LIHC were used to analyze the effects of DNA methylation level on SPP1 expression. SPP1 was overexpressed in HCC and correlated with T stage, histological grade, adjacent hepatic tissue inflammation, and vascular invasion in HCC. The analysis of survival rates indicated that high SPP1 levels were associated with poor overall survival in HCC. Functional analysis showed that SPP1 is related to tumor immunity, especially macrophage infiltration. Aberrant demethylation of the promoter region is one of the mechanisms underlying the increase of SPP1 in HCC. Our results indicate that SPP1 is an independent prognostic factor for HCC and is correlated with the clinical features and macrophage infiltration in HCC.

14 July 2025 in Radiation Oncology
Verified
Journal Article
Open access
PDF file
MLMingkun Liu
Mingkun Liu
TXTong Xia
Tong Xia
QXQianqian Xu
Qianqian Xu
YLYanfeng Liu
Yanfeng Liu
Liver cancer is a major contributor to cancer-related mortality. Selective internal radiation therapy (SIRT) for liver cancer has garnered increasing attention. This study aims to comprehensively describe the current status, hotspots and trends of SIRT. Publications from January 1, 1994, to May 31, 2024, were retrieved from the Web of Science Core Collection. CiteSpace, VOSviewer, the Bibliometrix package from R software, and an online analytical platform were used for knowledge mapping analysis and visualization. A total of 2046 publications were retrieved from the Web of Science Core Collection. The number of publications related to SIRT for liver cancer has been continuously increasing, particularly since 2005. The United States led in publications, and a strong collaboration network was observed among countries, particularly within Europe and America. The Northwestern University had the highest number of publications in the field of SIRT. Co-citation analysis identified “predictive dosimetry” and “atezolizumab” as current focal points within the field. High-frequency keywords include “transarterial radioembolization”, “Y90 microspheres”, “hepatocellular carcinoma”, while recent citation bursts are predominantly centered on “lung shunt fraction,” “tumor dose,” “systemic therapy,” “radiation segmentectomy,” “Holmium-166,” etc. As a local treatment, SIRT exhibits significant promise for its future role in the management of hepatic malignancies. Numerous studies on SIRT are actively in progress. Our study suggests that radiation segmentectomy may emerge as an important treatment in the future. Moreover, personalized dosimetry, the combination of SIRT with immunotherapy, and the development of novel radioactive agents are identified as pivotal areas for future research.